Correlation Between Psyence Biomedical and Seres Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Psyence Biomedical and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Psyence Biomedical and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Psyence Biomedical Ltd and Seres Therapeutics, you can compare the effects of market volatilities on Psyence Biomedical and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Psyence Biomedical with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Psyence Biomedical and Seres Therapeutics.

Diversification Opportunities for Psyence Biomedical and Seres Therapeutics

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Psyence and Seres is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Psyence Biomedical Ltd and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Psyence Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Psyence Biomedical Ltd are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Psyence Biomedical i.e., Psyence Biomedical and Seres Therapeutics go up and down completely randomly.

Pair Corralation between Psyence Biomedical and Seres Therapeutics

Considering the 90-day investment horizon Psyence Biomedical Ltd is expected to under-perform the Seres Therapeutics. In addition to that, Psyence Biomedical is 1.2 times more volatile than Seres Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Seres Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest  619.00  in Seres Therapeutics on September 4, 2024 and sell it today you would lose (526.00) from holding Seres Therapeutics or give up 84.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Psyence Biomedical Ltd  vs.  Seres Therapeutics

 Performance 
       Timeline  
Psyence Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Psyence Biomedical Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Seres Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Seres Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Psyence Biomedical and Seres Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Psyence Biomedical and Seres Therapeutics

The main advantage of trading using opposite Psyence Biomedical and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Psyence Biomedical position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.
The idea behind Psyence Biomedical Ltd and Seres Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.